Elevated WTAP expression in tumor-infiltrating CD8+ T cells enhances PD1 levels, suppressing proliferation and effector activity, whereas WTAP silencing—especially in combination with PD1 knockdown—restores immune function, inhibits tumor growth, and improves responses to PD-1 blockade. The gene discussed is CD8A; the disease is neoplasm.